Enveric Biosciences responds to FDA final guidance on psychedelic drug development

Go back to Enveric Biosciences responds to FDA final guidance on psychedelic drug development
(NASDAQ: ENVB) Delayed: 1.31 -0.04 (2.96%)
Previous Close $1.35    52 Week High
Open $1.38    52 Week Low
Day High $1.39    P/E N/A 
Day Low $1.25    EPS
Volume 176,685